Revlimid vs Trulicity
Side-by-side drug price comparison from Medicare Part D data
Verdict
Trulicity costs 96% less per claim than Revlimid ($473.00 vs $12786.00). Neither drug has a generic alternative available. Total Medicare spending: Revlimid at $7.8B vs Trulicity at $4.2B.
| Metric | Revlimid | Trulicity |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $12,786 | $473* |
| Total Medicare Spending Total Medicare Part D spending on this drug | $7.8B | $4.2B |
| Total Claims | 612,000 | 8,920,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | -3.4% | -4.8%* |
| Generic Available | No | No |
| Condition | Cancer | Diabetes |
| Total Beneficiaries | 58,000 | 985,000 |
Trulicity costs 96% less per claim than Revlimid ($473.00 vs $12786.00). Neither drug has a generic alternative available. Total Medicare spending: Revlimid at $7.8B vs Trulicity at $4.2B.